The cannabis research program at the University of Mississippi School of Pharmacy has partnered with pharmaceutical company Emerald Bioscience Inc. to license two new drug technologies that may provide nonaddictive pain management, prevent blindness and alleviate the threat of irreversible vision loss from glaucoma and other eye diseases. Read more.
First-year student pharmacists at the University of Mississippi School of Pharmacy gained a new perspective after participating in a recent Community Action Poverty Simulation, a program that is part of the Missouri Community Action Network. Read more.
Social Media Moments